Measuring telomerase activity for the early detection of cancer

Connecticut Medicine

Volumn 65, Issue 11, 2001, Pages 643-648

  Blechner, Michael D ^a   Mandavilli, Srinivas R ^a   Tsongalis, Gregory J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TELOMERE;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN; NEOPLASMS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TELOMERE;

EID: 0035514118     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Olovnikov AM: Telomeres, telomerase, and aging: Origin of the theory. Exp Gerontol 1996; 31:443-8.
2. Wright WE, Shay JW. Telomere dynamics in cancer progression and prevention: Fundamental differences in human and mouse telomere biology. Nat Med August 2000; 6:849-55.
3. Elledge SJ: Cell cycle checkpoints: Preventing an identity crisis. Science 1996; 274:1664-72.
4. Vaziri H, Benchimol S: Alternative pathways for the extension of cellular life span: Inactivation of p53/pRb and expression of telomerase. Oncogene 1999; 18:7676-80.
5. Hayflick L, Moorehead PS: The limited in vitro lifetime of human diploid cell strains. Exp Aging Res 1961; 25:585-621.
6. Shamblott MJ, Axelman J, Littlefield JW, et al: Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci U S A 2001; 98:113-8.
7. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer [see comments]. Science 1994; 266:2011-5.
8. Evans SK, Lundblad V: Positive and negative regulation of telomerase access to the telomere. J Cell Science 2000; 113:3357-64.
9. Sugino T, Yoshida K, Bolodeoku J, et al: Telomerase activity and its inhibition in benign and malignant breast lesions. J Pathol 1997; 183:57-61.
10. Poremba C, Bocker W, Willenbring H, et al: Telomerase activity in human proliferative breast lesions. Int J Clin Oncol 1998; 12:641-8.
11. Zhang W, Kapusta LR, Slingerland JM, Klotz LH: Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res 1998; 58:619-21.
12. Pao CC, Tseng CJ, Lin CY, et al: Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions. J Clin Oncol 1997; 15:1932-7.
13. Nagai N, Oshita T, Murakami J, Ohama K: Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions. Oncology Reports 1999; 6:325-8.
14. Avilion AA, Piatyszek MA, Gupta J, et al: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56:645-50.
15. Fossel M: Telomerase and the aging cell: Implications for human health. JAMA 1998; 279:1732-5.
16. Morii K, Tanaka R, Onda K, et al: Expression of telomerase RNA. telomerase activity, and telomere length in human gliomas. Biochem Biophys Res Commun 1997; 239:830-4.
17. Bodnar AG, Ouellette M, Frolkis M, et al: Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-52.
18. Saji M, Xydas S, Westra WH, et al: Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms. Clin Cancer Res 1999; 5:1483-9.
19. Umbricht CB, Saji M, Westra WH, et al: Telomerase activity: A marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res 1997; 57:2144-7.
20. Takahashi C, Miyagawa I, Kumano S, Oshimura M: Detection of telomerase activity in prostate cancer by needle biopsy. Eur Urol 1997; 32:494-8.
21. Ferlicot S, Paradis V, Dargere D, et al: Detection of telomerase in hepatocellular carcinomas using a PCR ELISA assay: Comparison with hTR expression. J Clin Pathol 1999; 52:725-9.
22. Weil RJ, Wu YY, Vortmeyer AO, et al: Telomerase activity in microdissected human gliomas. Mod Pathol 1999; 12:41-6.
23. Umbricht CB, Sherman ME, Dome J, et al: Telomerase activity in ductal carcinoma in situ and invasive breast cancer. Oncogene 1999; 18:3407-14.
24. Dome JS, Chung S, Bergemann T, et al: High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor. Cancer Res 1999; 59:4301-7.
25. De Marzo AM, Nelson WG, Meeker AK, Coffey DSL Stem cell features of benign and malignant prostate epithelial cells. J Urology 1998; 160(6 Pt 2):2381-92.
26. Saji M, Westra WH, Chen H, et al: Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid. Surgery 1997; 122:1137-40.
27. Brinkschmidt C, Poremba C, Christiansen H, et al: Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas. Brit J Cancer 1998; 77:2223-29.
28. Poremba C, Willenbring H, Hero B, et al: Telomerase activity distinguishes between neuroblastomas with good and poor prognosis. Ann Oncol 1999; 10:715-21.
29. Poremba C, Hero B, Heine B, et al: Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas. Med Pediatr Oncol 2000; 35:651-5.
30. Poremba C, Scheel C, Hero B, et al: Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: A molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues. J Clin Oncol 2000; 18:2582-92.
31. Ide T, Tahara H, Nakashio R, et al: Telomerase in hepatocellular carcinogenesis. Human Cell 1996; 9:283-6.
32. Tatsuma T, Goto S, Kitano S, et al: Telomerase activity in peripheral blood for diagnosis of hepatoma. J Gastroenterol Hepatol 2000; 15:1064-70.
33. Yashima K, Ashfaq R, Nowak J, et al:. Telomerase activity and expression of its RNA component in cervical lesions. Cancer 1998; 82:1319-27.
34. Carey LA, Hedican CA, Henderson GS, et al: Careful histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers. Clin Cancer Res 1998; 4:435-40.
35. Carey LA, Kim NW, Goodman S, et al: Telomerase activity and prognosis in primary breast cancers. J Clin Oncol 1999; 17:3075-81.
36. Clark GM, Osborne CK, Levitt D, et al: Telomerase activity and survival of patients with node-positive breast cancer. J National Cancer Institute 1997; 89:1874-81.
37. Poremba C, Shroyer KR, Frost M, et al: Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions [see comments]. J Clin Oncol 1999; 17:2020-6.